Ascent Group LLC Has $1.38 Million Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Ascent Group LLC lowered its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 13.1% during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 3,098 shares of the medical equipment provider’s stock after selling 466 shares during the quarter. Ascent Group LLC’s holdings in Intuitive Surgical were worth $1,378,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in ISRG. Creekmur Asset Management LLC grew its holdings in Intuitive Surgical by 200.0% in the 1st quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock valued at $25,000 after buying an additional 42 shares during the last quarter. Ridgewood Investments LLC acquired a new stake in Intuitive Surgical in the 2nd quarter valued at approximately $26,000. Able Wealth Management LLC acquired a new stake in Intuitive Surgical in the 4th quarter valued at approximately $28,000. Delos Wealth Advisors LLC grew its holdings in Intuitive Surgical by 380.0% in the 1st quarter. Delos Wealth Advisors LLC now owns 72 shares of the medical equipment provider’s stock valued at $29,000 after buying an additional 57 shares during the last quarter. Finally, LRI Investments LLC acquired a new stake in Intuitive Surgical in the 1st quarter valued at approximately $30,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Wall Street Analyst Weigh In

ISRG has been the subject of a number of research reports. Citigroup raised their price objective on Intuitive Surgical from $512.00 to $560.00 and gave the stock a “buy” rating in a research report on Thursday, August 22nd. Evercore ISI reduced their price objective on Intuitive Surgical from $425.00 to $410.00 and set an “in-line” rating for the company in a research report on Friday, July 19th. Redburn Atlantic upgraded Intuitive Surgical from a “neutral” rating to a “buy” rating and raised their price objective for the stock from $380.00 to $510.00 in a research report on Friday, August 2nd. Barclays raised their price objective on Intuitive Surgical from $430.00 to $490.00 and gave the stock an “overweight” rating in a research report on Thursday, July 18th. Finally, Robert W. Baird raised their price objective on Intuitive Surgical from $487.00 to $503.00 and gave the stock an “outperform” rating in a research report on Friday, July 19th. Six analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $446.45.

Intuitive Surgical Stock Performance

Shares of ISRG opened at $491.27 on Tuesday. The stock has a fifty day moving average price of $473.63 and a two-hundred day moving average price of $429.56. Intuitive Surgical, Inc. has a 52-week low of $254.85 and a 52-week high of $496.18. The company has a market cap of $174.25 billion, a price-to-earnings ratio of 88.68, a PEG ratio of 5.39 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Thursday, July 18th. The medical equipment provider reported $1.78 EPS for the quarter, beating the consensus estimate of $1.54 by $0.24. The company had revenue of $2.01 billion during the quarter, compared to analysts’ expectations of $1.97 billion. Intuitive Surgical had a return on equity of 13.04% and a net margin of 27.65%. The business’s revenue for the quarter was up 14.5% on a year-over-year basis. During the same period last year, the firm earned $1.18 EPS. As a group, research analysts predict that Intuitive Surgical, Inc. will post 5.22 EPS for the current fiscal year.

Insider Activity

In other news, insider Mark Brosius sold 2,115 shares of Intuitive Surgical stock in a transaction on Thursday, September 12th. The stock was sold at an average price of $491.91, for a total value of $1,040,389.65. Following the completion of the sale, the insider now directly owns 295 shares of the company’s stock, valued at approximately $145,113.45. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. In related news, insider Mark Brosius sold 2,115 shares of the company’s stock in a transaction dated Thursday, September 12th. The stock was sold at an average price of $491.91, for a total value of $1,040,389.65. Following the completion of the sale, the insider now owns 295 shares in the company, valued at $145,113.45. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Craig H. Barratt sold 1,400 shares of the company’s stock in a transaction dated Tuesday, July 23rd. The shares were sold at an average price of $458.13, for a total value of $641,382.00. The disclosure for this sale can be found here. In the last ninety days, insiders sold 53,120 shares of company stock valued at $25,528,753. Company insiders own 0.90% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.